This work unveils the functional significance of YBX1 in regulating autophagy and adipogenesis, suggesting a potential therapeutic strategy for treatment of obesity and metabolic diseases. The gene discussed is YBX1; the disease is obesity due to melanocortin 4 receptor deficiency.